Rare Cancers Should Not Be Second-Class Citizens of Cancer Research Says Antonio Lázaro Sánchez
Rare cancers, defined by the National Cancer Institute as those affecting fewer than 15 in 100,000 people annually, currently face systemic under-investment in clinical research. Antonio Lázaro Sánchez argues that ... Read More